physIQ Heart Rhythm and Respiratory Module vs Eko Low Ejection Fraction Tool (ELEFT)

Tool B, Eko Low Ejection Fraction Tool (ELEFT), offers a more immediate and integrated point-of-care experience by integrating with digital stethoscopes and providing results in approximately 15 seconds during routine physical exams. Its associated Eko CORE 500u00ae Digital Stethoscope has won a Red Dot Design Award for its intuitive user experience and seamless integration of clinical-grade capabilities. Tool A, physIQ, focuses on continuous remote monitoring, which involves a different, less immediate interaction model.

Both tools offer significant clinical value, but Tool B, Eko Low Ejection Fraction Tool (ELEFT), provides focused, rapid, point-of-care detection of low ejection fraction, a critical indicator of heart failure, with strong clinical validation. This direct, actionable insight during a routine physical exam can significantly aid in earlier diagnosis and intervention for a prevalent and serious condition. Tool A offers broader continuous monitoring for general decompensation and specific rhythm/respiratory issues, with evidence of predicting heart failure exacerbations.

While both tools require contacting sales for pricing, Tool B, Eko Low Ejection Fraction Tool (ELEFT), benefits from a provisional CMS reimbursement rate of $128.90 per use for its SENSORA platform. This established reimbursement pathway provides a clear financial incentive and recognized value for healthcare systems, offering greater transparency and accessibility for adoption. No comparable public pricing or reimbursement information is available for Tool A.

Both tools are explicitly designed as enterprise solutions, are cloud-based, FDA-cleared, HIPAA compliant, and offer BAAs. However, Tool B's SENSORA platform provides more explicit enterprise-specific features such as Single Sign-On (SSO), an Admin Dashboard for centralized data management, on-site training, and a dedicated customer success manager. These features indicate a slightly more comprehensive approach to large-scale deployment and ongoing support within healthcare systems.

Both tools demonstrate strong innovation. Tool A's personalized physiology analytics, which learn individual baselines from continuous wearable data to predict subtle decompensation, represents a foundational innovation in remote monitoring. However, Tool B's integration of AI for rapid, non-invasive detection of low ejection fraction directly into a routine physical exam using a digital stethoscope is a highly disruptive and accessible innovation for point-of-care diagnostics. This approach has been recognized with design awards and 'World Changing Ideas' awards.

Tool B, Eko Low Ejection Fraction Tool (ELEFT), is supported by a comprehensive 'Eko Help Center' that includes user manuals, FAQs, and multiple direct contact options for support, including scheduling phone calls and dedicated VIP customer support for its enterprise platform. Tool A lacks publicly available detailed support resources or documentation, with only general contact forms found.